In search for new sources of mesenchymal stem cells (MSCs) for renal repair in acute kidney
injury (AKI), we investigated the potential of human cord blood (CB)-MSCs to cure mice with …

Human umbilical cord blood-derived mesenchymal stem cells (HUCB-MSCs) have been
studied in several models of immune-mediated disease because of their unique …

Mesenchymal stem cells (MSCs) are candidates for cell therapy of kidney diseases.
However, the application of MSC derived from human umbilical cord (UC-MSC) in treating …

Mesenchymal stem cell is becoming a promising candidate in acute kidney injury (AKI). We
first reported that human umbilical cord mesenchymal stem cells (hucMSCs) could …

Administration of fibroblastic cells derived from a number of tissues (collectively called
“mesenchymal stem cells”) has been suggested to be beneficial for renal repair and …

Transplantation of bone marrow mesenchymal stem cells (BM-MSC) or stromal cells from
rodents has been identified as a strategy for renal repair in experimental models of acute …

Background/Aim: The kidney excretes waste materials and regulates important metabolic
functions, and renal disorders constitute a significant medical problem and can result in …

It is unknown whether human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)
can improve the renal function of patients suffering from acute kidney injury. Moreover …

Mesenchymal stem cells are currently considered as a promising tool for therapeutic
application in acute kidney injury (AKI) management. AKI is characterized by acute tubular …

Acute kidney injury (AKI) is a clinical syndrome associated with high rates of morbidity and
mortality. It has previously been reported that stem cells may be considered a potential …